Nucleosyn provides Custom Stable Isotope (2H, 13C, 15N) compounds to support projects dedicated to : Bioanalytics, Omics research, Molecular Imaging, and Biomarker discovery.
[D3]-Trabectedin
Trabectedin is an alkaloid anticancer drug used to treat advanced soft-tissue sarcoma and ovarian cancer. It is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Stable isotope labeled [D3]-Trabectedin is intended for use as an internal standard for the quantification of Trabectedin by LC or GC-mass spectrometry.
C39H40D3N3O11S
M. Briki et al., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2024, 1236, 124039. (read article)
E. Di Gregorio et al., J. Pharm. Biomed. Anal., 2020, 185, 113261. (read article)